All Stories

  1. Does topical minodixil in concentrations higher than 5% provide additional clinical benefit?
  2. Adverse outcome and severity of COVID ‐19 in patients with autoimmune bullous diseases: A historical cohort study
  3. Exacerbation of Autoimmune Bullous Diseases After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Is There Any Association?
  4. Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy
  5. A Young Boy with Brittle Hair
  6. Assessing quality of life in patients with autoimmune bullous diseases using the Persian version of Treatment of Autoimmune Bullous Disease Quality of Life questionnaire finds similar effects in women as men
  7. Evaluation of cephalometric indices in patients with obstructive sleep apnea in comparison with healthy individuals
  8. Pigmented purpuric dermatoses versus purpuric mycosis fungoides: Clinicopathologic similarities and new insights into dermoscopic features
  9. Comparison of the efficacy and safety of 308‐nm excimer laser with intralesional corticosteroids for the treatment of alopecia areata: A randomized controlled study
  10. Efficacy and safety of hydrogen peroxide topical solution in treating actinic keratosis: A randomized controlled trial
  11. Clinical and histopathological evaluation of cutaneous angiofibromas
  12. Nosocomial Infection Surveillance in Neonatal Intensive Care Units of Bahrami Children’s Hospital
  13. The Impact of Facial Asymmetry on the Surgical Outcome of Crooked Nose: A Case Control Study
  14. Lichen planus‐like lesions in 36 patients with pemphigus: A cross‐sectional study
  15. Rituximab in childhood and juvenile autoimmune bullous diseases as first-line and second-line treatment: a case series of 13 patients
  16. Cutaneous cysts: a clinicopathologic analysis of 2,438 cases
  17. Köbner Phenomenon in a Rituximab-Treated Pemphigus Patient: Beware Disease Activity